Silent coronary artery disease in type 2 diabetes mellitus: the role of Lipoprotein(a), homocysteine and apo(a) polymorphism.

Authors:
Gazzaruso C; Garzaniti A; Giordanetti S; Falcone C; Fratino P.

Journal:
Cardiovasc Diabetol

Publication Year: 2002

DOI:
10.1186/1475-2840-1-5

PMCID:
PMC149426

PMID:
12473160

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Cardiovasc Diabetol

Abbreviation: Cardiovasc Diabetol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Vascular Diseases

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Associations of combined polygenic risk score and glycemic status with atrial fibrillation, coronar…
Kim J; Kim D; Bae HJ and 9 more (2024) - Transparency Score: 3/6
Associations of the triglyceride-glucose index and atherogenic index of plasma with the severity of…
Wu X; Qiu W; Yang H and 3 more (2024) - Transparency Score: 3/6
Characterizing diabetic cardiomyopathy: baseline results from the ARISE-HF trial.
Januzzi JL; Del Prato S; Rosenstock J and 11 more (2024) - Transparency Score: 4/6
Characterizing the metabolic divide: distinctive metabolites differentiating CAD-T2DM from CAD pati…
Liu Y; Liu JE; He H and 7 more (2024) - Transparency Score: 3/6
Circulating exosomal mir-16-2-3p is associated with coronary microvascular dysfunction in diabetes …
Liu Y; Zhong C; Chen S and 4 more (2024) - Transparency Score: 4/6
View All Papers from This Journal
Transparency Score
0/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
COI Disclosure
Funding Disclosure
Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025